nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Vomiting—Melphalan—ovarian cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Immune system disorder—Docetaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Loss of consciousness—Paclitaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Mediastinal disorder—Docetaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Rash—Melphalan—ovarian cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Dermatitis—Melphalan—ovarian cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Chills—Docetaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Cough—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Asthenia—Vinorelbine—ovarian cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Dry skin—Epirubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Arrhythmia—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Convulsion—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Hypertension—Paclitaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Pruritus—Vinorelbine—ovarian cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Myalgia—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Chest pain—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Arthralgia—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Face oedema—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Erythema—Docetaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Nausea—Topotecan—ovarian cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Discomfort—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Cardiac arrest—Doxorubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Dry mouth—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Diarrhoea—Vinorelbine—ovarian cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Dysgeusia—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Nausea—Melphalan—ovarian cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Back pain—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Oedema—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Muscle spasms—Docetaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Eosinophilia—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Shock—Paclitaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Dizziness—Vinorelbine—ovarian cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Nervous system disorder—Paclitaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Tachycardia—Paclitaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Skin disorder—Paclitaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Vomiting—Vinorelbine—ovarian cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Rash—Vinorelbine—ovarian cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Dermatitis—Vinorelbine—ovarian cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Hypotension—Paclitaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Headache—Vinorelbine—ovarian cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Syncope—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Leukopenia—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Palpitations—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Loss of consciousness—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Cough—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Convulsion—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Paraesthesia—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Hypertension—Docetaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Dyspnoea—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Arthralgia—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Myalgia—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Chest pain—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Nausea—Vinorelbine—ovarian cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Dyspepsia—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Dry mouth—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Fatigue—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Pain—Paclitaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Anaphylactic shock—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Perflutren—Oedema—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Perflutren—Shock—Docetaxel—ovarian cancer	0.000988	0.000988	CcSEcCtD
Perflutren—Nervous system disorder—Docetaxel—ovarian cancer	0.000985	0.000985	CcSEcCtD
Perflutren—Tachycardia—Docetaxel—ovarian cancer	0.00098	0.00098	CcSEcCtD
Perflutren—Feeling abnormal—Paclitaxel—ovarian cancer	0.000976	0.000976	CcSEcCtD
Perflutren—Skin disorder—Docetaxel—ovarian cancer	0.000975	0.000975	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—ovarian cancer	0.00097	0.00097	CcSEcCtD
Perflutren—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000969	0.000969	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000963	0.000963	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—ovarian cancer	0.000956	0.000956	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—ovarian cancer	0.000955	0.000955	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—ovarian cancer	0.000953	0.000953	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—ovarian cancer	0.000948	0.000948	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—ovarian cancer	0.000946	0.000946	CcSEcCtD
Perflutren—Urticaria—Paclitaxel—ovarian cancer	0.000941	0.000941	CcSEcCtD
Perflutren—Hypotension—Docetaxel—ovarian cancer	0.000938	0.000938	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—ovarian cancer	0.000937	0.000937	CcSEcCtD
Perflutren—Abdominal pain—Paclitaxel—ovarian cancer	0.000936	0.000936	CcSEcCtD
Perflutren—Body temperature increased—Paclitaxel—ovarian cancer	0.000936	0.000936	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—ovarian cancer	0.000919	0.000919	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000915	0.000915	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—ovarian cancer	0.000901	0.000901	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—ovarian cancer	0.000898	0.000898	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—ovarian cancer	0.000895	0.000895	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—ovarian cancer	0.000891	0.000891	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—ovarian cancer	0.000889	0.000889	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—ovarian cancer	0.000886	0.000886	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—ovarian cancer	0.000885	0.000885	CcSEcCtD
Perflutren—Flushing—Epirubicin—ovarian cancer	0.000885	0.000885	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—ovarian cancer	0.000884	0.000884	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—ovarian cancer	0.000884	0.000884	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—ovarian cancer	0.000882	0.000882	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000877	0.000877	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—ovarian cancer	0.000875	0.000875	CcSEcCtD
Perflutren—Hypersensitivity—Paclitaxel—ovarian cancer	0.000873	0.000873	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000867	0.000867	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000867	0.000867	CcSEcCtD
Perflutren—Fatigue—Docetaxel—ovarian cancer	0.000866	0.000866	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—ovarian cancer	0.000865	0.000865	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—ovarian cancer	0.000861	0.000861	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—ovarian cancer	0.000859	0.000859	CcSEcCtD
Perflutren—Pain—Docetaxel—ovarian cancer	0.000859	0.000859	CcSEcCtD
Perflutren—Chills—Epirubicin—ovarian cancer	0.000855	0.000855	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—ovarian cancer	0.000851	0.000851	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—ovarian cancer	0.00085	0.00085	CcSEcCtD
Perflutren—Asthenia—Paclitaxel—ovarian cancer	0.00085	0.00085	CcSEcCtD
Perflutren—Pruritus—Paclitaxel—ovarian cancer	0.000838	0.000838	CcSEcCtD
Perflutren—Erythema—Epirubicin—ovarian cancer	0.00083	0.00083	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—ovarian cancer	0.000827	0.000827	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—ovarian cancer	0.000824	0.000824	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—ovarian cancer	0.000822	0.000822	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000821	0.000821	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—ovarian cancer	0.000818	0.000818	CcSEcCtD
Perflutren—Flushing—Doxorubicin—ovarian cancer	0.000818	0.000818	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—ovarian cancer	0.000812	0.000812	CcSEcCtD
Perflutren—Diarrhoea—Paclitaxel—ovarian cancer	0.00081	0.00081	CcSEcCtD
Perflutren—Back pain—Epirubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—ovarian cancer	0.000798	0.000798	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—ovarian cancer	0.000797	0.000797	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000795	0.000795	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—ovarian cancer	0.000794	0.000794	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—ovarian cancer	0.000794	0.000794	CcSEcCtD
Perflutren—Chills—Doxorubicin—ovarian cancer	0.000791	0.000791	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—ovarian cancer	0.000788	0.000788	CcSEcCtD
Perflutren—Dizziness—Paclitaxel—ovarian cancer	0.000783	0.000783	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—ovarian cancer	0.000782	0.000782	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—ovarian cancer	0.00077	0.00077	CcSEcCtD
Perflutren—Erythema—Doxorubicin—ovarian cancer	0.000768	0.000768	CcSEcCtD
Perflutren—Agitation—Epirubicin—ovarian cancer	0.000762	0.000762	CcSEcCtD
Perflutren—Vomiting—Paclitaxel—ovarian cancer	0.000753	0.000753	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—ovarian cancer	0.000752	0.000752	CcSEcCtD
Perflutren—Malaise—Epirubicin—ovarian cancer	0.000748	0.000748	CcSEcCtD
Perflutren—Rash—Paclitaxel—ovarian cancer	0.000747	0.000747	CcSEcCtD
Perflutren—Dermatitis—Paclitaxel—ovarian cancer	0.000746	0.000746	CcSEcCtD
Perflutren—Vertigo—Epirubicin—ovarian cancer	0.000745	0.000745	CcSEcCtD
Perflutren—Syncope—Epirubicin—ovarian cancer	0.000744	0.000744	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—ovarian cancer	0.000743	0.000743	CcSEcCtD
Perflutren—Back pain—Doxorubicin—ovarian cancer	0.000743	0.000743	CcSEcCtD
Perflutren—Headache—Paclitaxel—ovarian cancer	0.000742	0.000742	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—ovarian cancer	0.00074	0.00074	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—ovarian cancer	0.000738	0.000738	CcSEcCtD
Perflutren—Palpitations—Epirubicin—ovarian cancer	0.000733	0.000733	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—ovarian cancer	0.000729	0.000729	CcSEcCtD
Perflutren—Cough—Epirubicin—ovarian cancer	0.000724	0.000724	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—ovarian cancer	0.000724	0.000724	CcSEcCtD
Perflutren—Asthenia—Docetaxel—ovarian cancer	0.00072	0.00072	CcSEcCtD
Perflutren—Convulsion—Epirubicin—ovarian cancer	0.000719	0.000719	CcSEcCtD
Perflutren—Hypertension—Epirubicin—ovarian cancer	0.000716	0.000716	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000712	0.000712	CcSEcCtD
Perflutren—Pruritus—Docetaxel—ovarian cancer	0.00071	0.00071	CcSEcCtD
Perflutren—Chest pain—Epirubicin—ovarian cancer	0.000706	0.000706	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—ovarian cancer	0.000706	0.000706	CcSEcCtD
Perflutren—Myalgia—Epirubicin—ovarian cancer	0.000706	0.000706	CcSEcCtD
Perflutren—Agitation—Doxorubicin—ovarian cancer	0.000705	0.000705	CcSEcCtD
Perflutren—Nausea—Paclitaxel—ovarian cancer	0.000704	0.000704	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000702	0.000702	CcSEcCtD
Perflutren—Discomfort—Epirubicin—ovarian cancer	0.000698	0.000698	CcSEcCtD
Perflutren—Malaise—Doxorubicin—ovarian cancer	0.000692	0.000692	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—ovarian cancer	0.000691	0.000691	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—ovarian cancer	0.00069	0.00069	CcSEcCtD
Perflutren—Syncope—Doxorubicin—ovarian cancer	0.000688	0.000688	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—ovarian cancer	0.000687	0.000687	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—ovarian cancer	0.000687	0.000687	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—ovarian cancer	0.000678	0.000678	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—ovarian cancer	0.000677	0.000677	CcSEcCtD
Perflutren—Oedema—Epirubicin—ovarian cancer	0.000677	0.000677	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—ovarian cancer	0.000675	0.000675	CcSEcCtD
Perflutren—Cough—Doxorubicin—ovarian cancer	0.00067	0.00067	CcSEcCtD
Perflutren—Shock—Epirubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—ovarian cancer	0.000665	0.000665	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—ovarian cancer	0.000664	0.000664	CcSEcCtD
Perflutren—Dizziness—Docetaxel—ovarian cancer	0.000664	0.000664	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—ovarian cancer	0.000663	0.000663	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—ovarian cancer	0.000661	0.000661	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—ovarian cancer	0.000658	0.000658	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—ovarian cancer	0.000655	0.000655	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—ovarian cancer	0.000654	0.000654	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—ovarian cancer	0.000654	0.000654	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—ovarian cancer	0.000654	0.000654	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000649	0.000649	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—ovarian cancer	0.000646	0.000646	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—ovarian cancer	0.000639	0.000639	CcSEcCtD
Perflutren—Vomiting—Docetaxel—ovarian cancer	0.000638	0.000638	CcSEcCtD
Perflutren—Rash—Docetaxel—ovarian cancer	0.000633	0.000633	CcSEcCtD
Perflutren—Hypotension—Epirubicin—ovarian cancer	0.000633	0.000633	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—ovarian cancer	0.000632	0.000632	CcSEcCtD
Perflutren—Headache—Docetaxel—ovarian cancer	0.000629	0.000629	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000627	0.000627	CcSEcCtD
Perflutren—Oedema—Doxorubicin—ovarian cancer	0.000627	0.000627	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000617	0.000617	CcSEcCtD
Perflutren—Shock—Doxorubicin—ovarian cancer	0.000616	0.000616	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—ovarian cancer	0.000614	0.000614	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—ovarian cancer	0.000611	0.000611	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—ovarian cancer	0.000609	0.000609	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—ovarian cancer	0.000608	0.000608	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000606	0.000606	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Perflutren—Nausea—Docetaxel—ovarian cancer	0.000596	0.000596	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—ovarian cancer	0.000596	0.000596	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—ovarian cancer	0.000585	0.000585	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000585	0.000585	CcSEcCtD
Perflutren—Fatigue—Epirubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Perflutren—Pain—Epirubicin—ovarian cancer	0.000579	0.000579	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000571	0.000571	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—ovarian cancer	0.000563	0.000563	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—ovarian cancer	0.000559	0.000559	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—ovarian cancer	0.000558	0.000558	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000554	0.000554	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—ovarian cancer	0.000552	0.000552	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000541	0.000541	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—ovarian cancer	0.00054	0.00054	CcSEcCtD
Perflutren—Urticaria—Epirubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Perflutren—Pain—Doxorubicin—ovarian cancer	0.000536	0.000536	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—ovarian cancer	0.000535	0.000535	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—ovarian cancer	0.000535	0.000535	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—ovarian cancer	0.000516	0.000516	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000512	0.000512	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—ovarian cancer	0.000499	0.000499	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—ovarian cancer	0.000498	0.000498	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—ovarian cancer	0.000495	0.000495	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—ovarian cancer	0.000495	0.000495	CcSEcCtD
Perflutren—Asthenia—Epirubicin—ovarian cancer	0.000486	0.000486	CcSEcCtD
Perflutren—Pruritus—Epirubicin—ovarian cancer	0.000479	0.000479	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—ovarian cancer	0.000463	0.000463	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—ovarian cancer	0.000462	0.000462	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—ovarian cancer	0.00045	0.00045	CcSEcCtD
Perflutren—Dizziness—Epirubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—ovarian cancer	0.000443	0.000443	CcSEcCtD
Perflutren—Vomiting—Epirubicin—ovarian cancer	0.000431	0.000431	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—ovarian cancer	0.000429	0.000429	CcSEcCtD
Perflutren—Rash—Epirubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Perflutren—Headache—Epirubicin—ovarian cancer	0.000424	0.000424	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—ovarian cancer	0.000414	0.000414	CcSEcCtD
Perflutren—Nausea—Epirubicin—ovarian cancer	0.000402	0.000402	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—ovarian cancer	0.000398	0.000398	CcSEcCtD
Perflutren—Rash—Doxorubicin—ovarian cancer	0.000395	0.000395	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—ovarian cancer	0.000395	0.000395	CcSEcCtD
Perflutren—Headache—Doxorubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Perflutren—Nausea—Doxorubicin—ovarian cancer	0.000372	0.000372	CcSEcCtD
